Literature DB >> 27196022

Impact of Race and Insurance Status on Surgical Approach for Cervical Spondylotic Myelopathy in the United States: A Population-Based Analysis.

Shearwood McClelland1, Bryan J Marascalchi2, Peter G Passias1, Themistocles S Protopsaltis1, Anthony K Frempong-Boadu3, Thomas J Errico1.   

Abstract

STUDY
DESIGN: Retrospective cohort study.
OBJECTIVE: The aim of the study was to assess factors potentially impacting the operative approach chosen for cervical spondylotic myelopathy (CSM) patients on a nationwide level. SUMMARY OF BACKGROUND DATA: CSM is one of the most common spinal disorders treated by spine surgeons, with operative management consisting of three approaches: anterior-only, posterior-only, or combined anterior-posterior. It is unknown whether the operative approach used differs based on patient demographics and/or insurance status.
METHODS: The nationwide inpatient sample from 2001 to 2010 was used for analysis. Admissions having a diagnosis code of 721.1 and a primary procedure code of 81.02/81.03, 81.32/81.33, 81.02/81.03, or 81.32/81.33 (combined anterior and posterior fusion/refusion at C2 or below), and 3.09 (decompression of the spinal canal including laminoplasty) were included. Analysis was adjusted for several variables including patient age, race, sex, primary payer for care, and admission source/type.
RESULTS: Multivariate analyses revealed that non-white race (black [odds ratio, OR = 1.39; 95% confidence interval, CI = 1.32-1.47; P < 0.0001], Hispanic [OR = 1.51; 95% CI = 1.38-1.66; P < 0.0001], Asian/Pacific Islander [OR = 1.40; 95% CI = 1.15-1.70; P = 0.0007], Native American [OR = 1.33; 95% CI = 1.02-1.73; P = 0.037]) and increasing age (OR = 1.03; P < 0.0001) were predictive of receiving posterior-only approaches. Female sex (OR = 1.39; 95% CI = 1.34-1.43; P < 0.0001), private insurance (OR = 1.19; 95% CI = 1.14-1.25; P < 0.0001), and nontrauma center admission type (OR = 1.29-1.39; 95% CI = 1.16-1.56; P < 0.0001) were independently predictive of increased likelihood of receiving an anterior-only approach. Hispanic race (OR = 1.35; 95% CI = 1.14-1.59; P = 0.0004) and admission source (another hospital [OR = 1.65; 95% CI = 1.20-2.27; P = 0.0023], other health facility [OR = 1.68; 95% CI = 1.13-2.51; P = 0.011]) were the only variables predictive of increased combined anterior-posterior approaches; Native American race (OR = 0.32; 95% CI = 0.13-0.78; P = 0.013) decreased the likelihood of a combined anterior-posterior approach.
CONCLUSION: Private insurance status, female sex, and white race independently predict receipt of anterior-only CSM approaches, whereasd non-white race (black, hispanic, Asian/Pacific Islander, Native American) and nonprivate insurance predict receiving posterior-only CSM approaches. Given recent literature demonstrating posterior-only approaches as predictive of increased mortality in CSM (Kaye et al, 2015), our findings indicate that for CSM patients, non-white race may significantly increase mortality risk, whereas private insurance status may significantly decrease the risk of mortality. Further prospective study will be needed to more definitively address these issues. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2017        PMID: 27196022     DOI: 10.1097/BRS.0000000000001693

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  Socioeconomic and regional differences in the treatment of cervical spondylotic myelopathy.

Authors:  Sheri K Palejwala; Anand I Rughani; G Michael Lemole; Travis M Dumont
Journal:  Surg Neurol Int       Date:  2017-05-26

2.  Racial Disparities in Surgical Outcomes After Spine Surgery: An ACS-NSQIP Analysis.

Authors:  Zachary Sanford; Haley Taylor; Alyson Fiorentino; Andrew Broda; Amina Zaidi; Justin Turcotte; Chad Patton
Journal:  Global Spine J       Date:  2018-12-30

Review 3.  Development and Achievement of Cervical Laminoplasty and Related Studies on Cervical Myelopathy.

Authors:  Shigeru Hirabayashi; Tomoaki Kitagawa; Iwao Yamamoto; Kazuaki Yamada; Hirotaka Kawano
Journal:  Spine Surg Relat Res       Date:  2019-07-10

4.  Degenerative Cervical Myelopathy: Development and Natural History [AO Spine RECODE-DCM Research Priority Number 2].

Authors:  Aria Nouri; Enrico Tessitore; Granit Molliqaj; Torstein Meling; Karl Schaller; Hiroaki Nakashima; Yasutsugu Yukawa; Josef Bednarik; Allan R Martin; Peter Vajkoczy; Joseph S Cheng; Brian K Kwon; Shekar N Kurpad; Michael G Fehlings; James S Harrop; Bizhan Aarabi; Vafa Rahimi-Movaghar; James D Guest; Benjamin M Davies; Mark R N Kotter; Jefferson R Wilson
Journal:  Global Spine J       Date:  2022-02

5.  Establishing the Socio-Economic Impact of Degenerative Cervical Myelopathy Is Fundamental to Improving Outcomes [AO Spine RECODE-DCM Research Priority Number 8].

Authors:  Benjamin M Davies; Richard Phillips; David Clarke; Julio C Furlan; Andreas K Demetriades; Jamie Milligan; Christopher D Witiw; James S Harrop; Bizhan Aarabi; Shekar N Kurpad; James D Guest; Jefferson R Wilson; Brian K Kwon; Alexander R Vaccaro; Michael G Fehlings; Vafa Rahimi-Movaghar; Mark R N Kotter
Journal:  Global Spine J       Date:  2022-02

6.  Navigator-assisted hypofractionation (NAVAH) to address radiation therapy access disparities facing African-Americans with breast cancer.

Authors:  Shearwood McClelland; Eleanor E Harris; Daniel E Spratt; Chesley Cheatham; Yilun Sun; Alexandria L Oliver; Jerry J Jaboin; Reshma Jagsi; Daniel G Petereit
Journal:  Rep Pract Oncol Radiother       Date:  2022-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.